Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report.
Pozas J, Albarrán-Fernández V, González-Campo L, Olmedo-García ME, Corral de la Fuente E, Corral-Corral I, Carrasco Á, Alonso-Gordoa T, Molina-Cerrillo J, Lage-Alfranca Y, Gómez-Rueda A, Garrido P. Pozas J, et al. Transl Lung Cancer Res. 2022 Jul;11(7):1497-1502. doi: 10.21037/tlcr-21-989. Transl Lung Cancer Res. 2022. PMID: 35958343 Free PMC article.
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.
Albarrán V, Villamayor ML, Chamorro J, Rosero DI, Pozas J, San Román M, Calvo JC, Pérez de Aguado P, Moreno J, Guerrero P, González C, García de Quevedo C, Álvarez-Ballesteros P, Vaz MÁ. Albarrán V, et al. Among authors: pozas j. Int J Mol Sci. 2022 Nov 9;23(22):13784. doi: 10.3390/ijms232213784. Int J Mol Sci. 2022. PMID: 36430263 Free PMC article. Review.
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma.
San-Román-Gil M, Torres-Jiménez J, Pozas J, Esteban-Villarrubia J, Albarrán-Fernández V, Álvarez-Ballesteros P, Chamorro-Pérez J, Rosero-Rodríguez D, Orejana-Martín I, Martínez-Delfrade Í, Reguera-Puertas P, Fuentes-Mateos R, Ferreiro-Monteagudo R. San-Román-Gil M, et al. Among authors: pozas j. Cancers (Basel). 2023 Jan 30;15(3):863. doi: 10.3390/cancers15030863. Cancers (Basel). 2023. PMID: 36765821 Free PMC article. Review.
Current Landscape of Immunotherapy for Advanced Sarcoma.
Albarrán V, Villamayor ML, Pozas J, Chamorro J, Rosero DI, San Román M, Guerrero P, Pérez de Aguado P, Calvo JC, García de Quevedo C, González C, Vaz MÁ. Albarrán V, et al. Among authors: pozas j. Cancers (Basel). 2023 Apr 13;15(8):2287. doi: 10.3390/cancers15082287. Cancers (Basel). 2023. PMID: 37190214 Free PMC article. Review.
Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.
Albarrán V, Chamorro J, Pozas J, San Román M, Rosero DI, Saavedra C, Gion M, Cortés A, Escalera E, Guerra E, López Miranda E, Fernández Abad M, Martínez Jañez N. Albarrán V, et al. Among authors: pozas j. Front Oncol. 2023 May 5;13:1158981. doi: 10.3389/fonc.2023.1158981. eCollection 2023. Front Oncol. 2023. PMID: 37213307 Free PMC article.
Adoptive T cell therapy for solid tumors: current landscape and future challenges.
Albarrán V, San Román M, Pozas J, Chamorro J, Rosero DI, Guerrero P, Calvo JC, González C, García de Quevedo C, Pérez de Aguado P, Moreno J, Cortés A, Soria A. Albarrán V, et al. Among authors: pozas j. Front Immunol. 2024 Mar 14;15:1352805. doi: 10.3389/fimmu.2024.1352805. eCollection 2024. Front Immunol. 2024. PMID: 38550594 Free PMC article. Review.
26 results